Phase II trial of Alimta (pemetrexed) and Gemzar (gemcitabine) in metastatic breast cancer patients who have received prior taxane therapy.
Phase of Trial: Phase II
Latest Information Update: 20 May 2009
At a glance
- Drugs Gemcitabine; Pemetrexed
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 20 May 2009 Actual patient number (43) added as reported by ClinicalTrials.gov.
- 07 Feb 2008 Status change from in progress to completed.
- 16 Jan 2007 Status change